IPO

Zenith Drugs Ltd. IPO

Zenith Drugs Ltd., established in 2000, operates in the Pharmaceuticals sector. The company's IPO opened on February 19, 2024 and closed on February 22, 2024, with an issue price of ₹79. The Zenith ... Read more

Min Investment
₹ 1,26,400 / 1600 shares
Price Range
₹75 - ₹ 79
Bidding Dates
19 Feb '24 - 22 Feb '24
Total Issue Value
40.68 Cr
Lot Size
1,600
Total Issue Size
40.68 Cr
Listing At
NSE SME
Subscription
156.70 times
NSE Price
80.80 (2.28%)

IPO Timeline

  • 19 Feb 2024
    Bidding Starts
  • 22 Feb 2024
    Bidding Ends
  • 23 Feb 2024
    Allotment Finalization
  • 27 Feb 2024
    Listing

About Zenith Drugs Ltd.

We at Zenith are a reputable pharmaceutical manufacturing unit, dedicated to ensuring the highest quality standards. We are proud to be WHO-GMP compliant, adhering to the stringent guidelines set by the World Health Organization. Our commitment to quality is further demonstrated by our ISO ... Read more

Parent organisation
Founded
Zenith Drugs Ltd.
2000

Zenith Drugs Ltd. IPO Reservation

Investors Category Shares Offered
Anchor Investors 12,88,320 (25.02%)
Market Makers 8,52,800 (16.56%)
Non Institutional Investors 6,44,800 (12.52%)
Qualified Institutional Buyers (QIBs) 8,58,880 (16.68%)
Retail Individual Investors (RIIs) 15,04,000 (29.21%)

Zenith Drugs Ltd. Financial Information

Year End Revenue PAT Reserves & Surplus
31 Mar 2024 133.74 Cr 10.99 Cr 45.07 Cr
31 Mar 2023 115.76 Cr 4.88 Cr 17.33 Cr
31 Mar 2022 92.60 Cr 3.21 Cr 12.45 Cr

Zenith Drugs Ltd. Background

Our Company was originally incorporated on November 15, 2000 as a Private Limited Company in the name of “Zenith Drugs Private Limited” under the provisions of the Companies Act, 1956 with the Registrar of Companies, Madhya Pradesh, Gwalior. Subsequently pursuant to a Special ...

Read more

Major Events And Milestones
  • 2000
    Incorporation of the Company.
  • 2001
    Started as a manufacturing house for oral and external formulations.
  • 2004
    Shifted to a Schedule M GMP compliant unit.
    Started the production of two lines which are liquid orals and ointments.
  • 2007
    Started manufacturing ORS Powder
  • 2016
    Received WHO GMP certification
  • 2019
    Turnover crossed 50 Crores.
  • 2020
    Turnover crossed 75 Crores.
  • 2021
    Certificate of Quality Management System ISO 9001:2015 issued by Global Grading Certification
    Certificate of compliance with good manufacturing practices issued by Liberia Medicines and Health Products Regulatory Authority
    Our Company received subsidy under Madhya Pradesh MSME Yojna i.e. MSME Promotion Scheme,2019 as Industrial Development Grant upto 40% of the capital invested in machinery i.e. grant of ₹170.04 Lakhs
  • 2022
    The Company was recognized as among top 10 MSME Pharmaceutical Manufacturers in Indore in Industry Outlook Magazine Edition.
  • 2023
    Turnover crossed 100 Crores.
    Collaborated with Mr. Kshatriya Valtaprasad Nandkishore for Carrying out the task of Marketing and Export of the products manufactured by Zenith.
    Conversion of our Company from Private Limited Company to Public Limited Company.
Zenith Drugs Ltd. Object of Issues

1. Purchase of Machinery & Equipments for Setting up New Unit
2. Existing Manufacturing Block Upgradation
3. Working Capital Requirements
4. General Corporate Purposes

Zenith Drugs Ltd. IPO Listing Details
Listing Date
27 Feb 2024
NSE Symbol
ZENITHDRUG
ISIN
INE0QWN01013
Final Issue Price
₹ 79
Zenith Drugs Ltd. Listing Day Trading Information
Pricing Details BSE NSE
Issue Price - ₹ 79.00
Open - ₹ 110.00
Low - ₹ 104.50
High - ₹ 114.50
Last Trade - ₹ 105.15
Zenith Drugs Ltd. Company Promoters

1. Mr. Sandeep Bhardwaj
2. Mr. Bhupesh Soni
3. Mr. Ajay Singh Dassundi

Industry Overview

India is the largest provider of generic drugs globally and is known for its affordable vaccines and generic medications. The Indian Pharmaceutical industry is currently ranked third in pharmaceutical production by volume after evolving over time into a thriving industry growing at a CAGR of ... Read more

Zenith Drugs Ltd. Contact Details
Address: K. No. 72 / 5, Village Muradpura, NA, Depalpur, Indore Madhya Pradesh - 453001
Phone no:8435501867
8435501867
|
Zenith Drugs Ltd. IPO Registrar
Bigshare Services Private Limited.
S6-2, 6th Floor, Pinnacle Business Park, Mahakali Caves Road, Next to Ahura Centre, Andheri East, Mumbai Maharashtra - 400093
62638200
Zenith Drugs Ltd. IPO Lead Manager(s)
Gretex Corporate Services Ltd.
A-401, Floor 4th, Plot FP-616, (PT), Naman Midtown, Senapati Bapat Marg, Near Indiabulls, Dadar (w), Delisle Road, Mumbai Maharashtra - 400013

FAQs

When does Zenith Drugs Ltd. IPO opens and closes?

Zenith Drugs Ltd. IPO opens from 19th February to 22nd February 2024.

What is the size of Zenith Drugs Ltd. IPO?

The size of the Zenith Drugs Ltd. IPO is ₹40.68 Cr.

What is the price range of Zenith Drugs Ltd. IPO?

The price range of Zenith Drugs Ltd. IPO is at ₹75 to ₹79 per share.

What is the minimum investment and lot size required for the Zenith Drugs Ltd. IPO?

The minimum investment required is ₹1,26,400 and minimum lot size is 1600 shares.

When is Zenith Drugs Ltd. IPO listing date?

The Zenith Drugs Ltd. IPO will be listed on 27th February 2024.

What is the objective of Zenith Drugs Ltd. IPO?

1. Purchase of Machinery & Equipments for Setting up New Unit
2. Existing Manufacturing Block Upgradation
3. Working Capital Requirements
4. General Corporate Purposes

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article

Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
  • Block for 8 hours
  • Block for 12 hours
  • Block for 24 hours
  • Don't block
Gender
Select your Gender
  • Male
  • Female
  • Others
Age
Select your Age Range
  • Under 18
  • 18 to 25
  • 26 to 35
  • 36 to 45
  • 45 to 55
  • 55+